Suvorexant, an orexin receptor antagonist, in preventing symptom return in patients with insomnia after 1 year of treatment: a randomised, double-blind, placebo-controlled study
Publication
, Conference
Herring, WJ; Snyder, E; Paradis, E; Hutzelmann, J; Liu, M-C; Snavely, D; Walsh, J; Krystal, A; Roth, T; Michelson, D
Published in: JOURNAL OF SLEEP RESEARCH
2012
Duke Scholars
Published In
JOURNAL OF SLEEP RESEARCH
ISSN
0962-1105
Publication Date
2012
Volume
21
Start / End Page
351 / 351
Related Subject Headings
- Neurology & Neurosurgery
- 52 Psychology
- 32 Biomedical and clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Herring, W. J., Snyder, E., Paradis, E., Hutzelmann, J., Liu, M.-C., Snavely, D., … Michelson, D. (2012). Suvorexant, an orexin receptor antagonist, in preventing symptom return in patients with insomnia after 1 year of treatment: a randomised, double-blind, placebo-controlled study. In JOURNAL OF SLEEP RESEARCH (Vol. 21, pp. 351–351).
Herring, W. J., E. Snyder, E. Paradis, J. Hutzelmann, M. -. C. Liu, D. Snavely, J. Walsh, A. Krystal, T. Roth, and D. Michelson. “Suvorexant, an orexin receptor antagonist, in preventing symptom return in patients with insomnia after 1 year of treatment: a randomised, double-blind, placebo-controlled study.” In JOURNAL OF SLEEP RESEARCH, 21:351–351, 2012.
Herring WJ, Snyder E, Paradis E, Hutzelmann J, Liu M-C, Snavely D, et al. Suvorexant, an orexin receptor antagonist, in preventing symptom return in patients with insomnia after 1 year of treatment: a randomised, double-blind, placebo-controlled study. In: JOURNAL OF SLEEP RESEARCH. 2012. p. 351–351.
Herring, W. J., et al. “Suvorexant, an orexin receptor antagonist, in preventing symptom return in patients with insomnia after 1 year of treatment: a randomised, double-blind, placebo-controlled study.” JOURNAL OF SLEEP RESEARCH, vol. 21, 2012, pp. 351–351.
Herring WJ, Snyder E, Paradis E, Hutzelmann J, Liu M-C, Snavely D, Walsh J, Krystal A, Roth T, Michelson D. Suvorexant, an orexin receptor antagonist, in preventing symptom return in patients with insomnia after 1 year of treatment: a randomised, double-blind, placebo-controlled study. JOURNAL OF SLEEP RESEARCH. 2012. p. 351–351.
Published In
JOURNAL OF SLEEP RESEARCH
ISSN
0962-1105
Publication Date
2012
Volume
21
Start / End Page
351 / 351
Related Subject Headings
- Neurology & Neurosurgery
- 52 Psychology
- 32 Biomedical and clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences